Please ensure Javascript is enabled for purposes of website accessibility

2 Top Marijuana Stocks to Buy in January

By Zhiyuan Sun - Jan 20, 2021 at 6:29AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

These pot growers are shattering their own revenue growth records.

Marijuana stocks have been on fire lately. Many investors are hoping that a Democratic-controlled senate will steer the U.S. on the path to decriminalization -- or even to legalization of the drug at the federal level. If -- and it's a big "if" -- legalization did happen, it would create the world's biggest cannabis industry with over $100 billion in annual sales.

In the past month, the Horizons Medical Marijuana Life Sciences ETF (HMMJ -1.82%), a leading indicator of pot stocks, is already up over 12%. That's just below the S&P 500's 12.8% return over the same period. Given all the enthusiasm, let's take a look at two of the best marijuana companies to choose from this January. 

Woman holding a cannabis leaf in a hemp growing field.

Image source: Getty Images.

1. Aphria

Aphria (APHA) and medical cannabis company Tilray (TLRY) will merge this year to form the biggest marijuana grower in the world, with nearly 900 million Canadian dollars in annual revenue. The combined entity is well positioned to expand into the U.S. cannabis market, with its line of beverages and cannabidiol (CBD) products available at tens of thousands of retail locations throughout North America.

During the fiscal second quarter of 2021 (ended Nov. 30, 2020), Aphria increased its sales by 33% year over year to CA$160.5 million. Simultaneously, its cash production cost per gram of cannabis fell 6% quarter over quarter to CA$0.79. After adjusting for changes in its convertibles' fair value, one-time transaction costs, and share compensation expenses, the company posted a surprise profit of CA$0.01 per share.

It is quite remarkable for a pot grower to become profitable while it is expanding. The company's free cash flow also improved by as much as CA$70 million over the past quarter.

Right now, Aphria sees significant demand for its Canadian pot business as well. It managed to sell approximately 26,730 kilograms of cannabis in Q2 2021, up from 20,880 kg sold in the previous quarter. Given the potential for its momentum to continue, I highly recommend marijuana investors pick up shares of Aphria, even while it's trading at about eight times revenue.

2. HEXO

Pot grower HEXO (HEXO -5.11%) sports the largest market share in the Canadian province of Quebec. It, too, is eyeing the multi-billion cannabis opportunity south of the border. Currently, HEXO runs a joint venture with Molson Coors Brewing Company (TAP 0.89%) to develop its line of CBD-infused beverages. The partnership's CBD sparkling water was just launched in Colorado.

Despite being a relatively new venture, its beverages are already wildly successful. HEXO now holds a 54% market share in Canada's cannabis drinks industry, a title previously held by Canopy Growth (CGC -5.96%).

Back in the first quarter of 2021 (ended Oct. 31), HEXO's beverage revenue totaled CA$3 million, a sizable increase over the CA$2 million it brought in during the previous quarter. Moreover, the company managed to break even in terms of gross profit, compared to a negative gross margin of 121% in the fourth quarter of 2020.

It also should be noted that HEXO is more than doubling its sales year after year and is very close to breaking even. Furthermore, its CA$150 million in cash more than offsets the company's CA$59 million in debt and convertibles. Trading at about 9 times revenue, HEXO's growth premium is well worth it. Investors should expect the company to break past its earnings estimate as it makes the most of its leading role with its pot beverage brands.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

HEXO Stock Quote
HEXO
HEXO
$0.28 (-5.11%) $0.02
Molson Coors Beverage Company Stock Quote
Molson Coors Beverage Company
TAP
$51.23 (0.89%) $0.45
Canopy Growth Stock Quote
Canopy Growth
CGC
$5.52 (-5.96%) $0.35
Horizons Marijuana Life Sciences Index ETF Stock Quote
Horizons Marijuana Life Sciences Index ETF
HMMJ
$4.32 (-1.82%) $0.08
Tilray Stock Quote
Tilray
TLRY
Aphria Stock Quote
Aphria
APHA

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
330%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/21/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.